Email updates

Keep up to date with the latest news and content from Clinical Epigenetics and BioMed Central.

Open Access Highly Accessed Review

A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States

Renee Dufault12*, Walter J Lukiw3, Raquel Crider4, Roseanne Schnoll5, David Wallinga6 and Richard Deth7

Author Affiliations

1 Food Ingredient and Health Research Institute, Ocean View, HI, USA

2 United Tribes Technical College, Bismarck, ND, USA

3 Department of Neuroscience and Ophthalmology, Louisiana State University Neuroscience Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA

4 Shepherd University, Shepherdstown, WV, USA

5 Department of Health and Nutrition Sciences, Brooklyn College of City, University of New York, Brooklyn, NY, USA

6 Institute for Agriculture and Trade Policy, Minneapolis, MN, USA

7 Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA

For all author emails, please log on.

Clinical Epigenetics 2012, 4:6  doi:10.1186/1868-7083-4-6

The electronic version of this article is the complete one and can be found online at: http://www.clinicalepigeneticsjournal.com/content/4/1/6


Received:9 December 2011
Accepted:10 April 2012
Published:10 April 2012

© 2012 Dufault et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The number of children ages 6 to 21 in the United States receiving special education services under the autism disability category increased 91% between 2005 to 2010 while the number of children receiving special education services overall declined by 5%. The demand for special education services continues to rise in disability categories associated with pervasive developmental disorders. Neurodevelopment can be adversely impacted when gene expression is altered by dietary transcription factors, such as zinc insufficiency or deficiency, or by exposure to toxic substances found in our environment, such as mercury or organophosphate pesticides. Gene expression patterns differ geographically between populations and within populations. Gene variants of paraoxonase-1 are associated with autism in North America, but not in Italy, indicating regional specificity in gene-environment interactions. In the current review, we utilize a novel macroepigenetic approach to compare variations in diet and toxic substance exposure between these two geographical populations to determine the likely factors responsible for the autism epidemic in the United States.

Keywords:
Autism; DNA methylation; Environmental epigenetics; Heavy metals; HFCS; PON1; SAM; Zn

Introduction to macroepigenetics with autism as a case study

Autism is a developmental disorder defined by the American Psychiatric Association (APA) in the Diagnostic and Statistical Manual of Mental Disorders (DSM). The condition is considered a pervasive developmental disorder (PDD) that appears in the first three years of life and affects brain development impacting social and communication skills. Autism is defined by a common set of behaviors, including, but not limited to, observed deficits in nonverbal and verbal communication, lack of social reciprocity, and failure to develop and maintain appropriate peer relationships [1]. Recent estimates suggest that 31% of children with Autism Spectrum Disorder (ASD) also meet diagnostic criteria for Attention-Deficit/Hyperactivity Disorder (ADHD) and another 24% of children with ASD exhibit sub-threshold clinical symptoms for ADHD [2]. The number of children affected by this debilitating disorder remains unknown. As part of this review, we analyze the current United States (U. S.) Department of Education Special Education data to estimate the increase in autism prevalence from 2005 to 2010.

The cause(s) of autism also remain(s) unknown. D'Amelio et al. found paraoxonase-1 (PON1) gene variants associated with autism in subgroups of the U. S. population but not in Italy [3]. They attributed the gene variation to greater household use of organophosphate (OP) pesticides in the U.S. compared to Italy. We think a more plausible explanation may lie in the U. S. food supply. As part of this investigation, we also reviewed and analyzed the U.S. Department of Agriculture (USDA) Food Availability Spreadsheets to identify which foods are most frequently consumed by Americans and of those which most frequently contain OP pesticide residue as reported by the U.S. Pesticide Data Program.

During this investigation, we conducted a literature review of all studies published on autism since we published our first Mercury Toxicity Model [4], which explains how mercury exposure, nutritional deficiencies and metabolic disruptions contribute to the development of autism. We evaluated all of the relevant studies and expanded our Mercury Toxicity Model. We then used the expanded model to compare the U.S. and Italian populations to determine what, if any, factors could explain the difference in PON1 gene variation and autism prevalence between the two countries. We propose the term "macroepigenetics" to describe the process of examining food supplies and their impact on body metabolism and gene function along with what is known about environmental exposures across populations.

In studying the larger factors outside the gene and human body that impact gene expression, we can better explain some of the gene-environment interactions that create disease conditions such as autism. There is agreement among many in the psychiatry profession that gene-environment interaction research is essential to understanding the etiology of autism and the other pervasive developmental disorders found in the ASD category [5]. How the scientific community arrives at this understanding is key to solving the problem of rising autism prevalence. By demonstrating the macroepigenetic approach to determine the factors likely responsible for the autism prevalence in the U.S., we hope more scientists will follow our interdisciplinary lead and use macroepigenetics as a research strategy.

Current U. S. autism prevalence and special education trends

Before the 1980s the prevalence of autism in the U. S. was about 0.05% [6]. In 2006, the Center for Disease Control and Prevention (CDC) reported that the estimated prevalence of autism had increased to between 0.6 and 0.7% of all children [7]. Many scientists and parents believe the autism prevalence rate in the U.S. is much higher than these CDC statistics indicate. U.S. government scientists and collaborators published an article in 2007 indicating that 1.1% of U.S. children aged 3 to 17 years were currently diagnosed with ASD [8].

Special education data have been used in the past to estimate autism prevalence trends in the U.S. [9]. In birth cohorts from 1975 to 1995, increases in autism were greatest for annual cohorts born from 1987 to 1992 [9]. From 1992 to 1995, the autism prevalence increased with each successive year but the increases did not appear as great [9]. Our review of the current special education data indicates the number of children ages 6 to 21 receiving special education services under the Autism category has increased 91% from 2005 to 2010. The number of children in the Developmental Delay category has increased 38% and the number of children receiving special education and related services under the Other Health Impaired (OHI) category has increased 26% from 2005 to 2010. Children with a diagnosis of ADHD are included in the OHI category. These increases are startling given that the overall number of children receiving special education services decreased by 5% from 2005 to 2010. Table 1 provides a graphical representation of the data obtained from the Data Accountability Center and analyzed during this review [10].

Table 1. Number of U.S. students ages 6 to 21 receiving special education services by disability category and year

Data from the 1997 to 2008 National Health Interview Surveys conducted by the CDC confirm these findings of increasing prevalence in autism and developmental disabilities associated with or sharing the diagnostic criteria for autism [11]. Regardless of the source of data it seems clear that autism prevalence is rising in the U.S. compared to other countries, such as Italy, where the autism prevalence in the general population is estimated at only 0.1% [12]. Because autism prevalence rates vary by country, population and geographic location, it is becoming more evident that gene-environment interactions are at play with dietary factors. The influence of environment factors on gene expression is primarily mediated by epigenetic mechanisms, including deoxyribonucleic acid (DNA) methylation along with methylation, acetylation, ubiquitination and phosphorylation of histones. Epigenetic regulation is particularly important during neurodevelopment [13].

A macroepigenetic model to explain gene-environment interactions in autism

In public health, epidemiology arguably has led the way in researching gene-environment interactions by studying how genotypes, environmental exposures and disorder outcomes occur in the human population [5]. However, this epidemiological approach has often resulted in contradictory scientific conclusions when its practitioners do not consider the dietary factors that interact and modulate the molecular and genetic mechanisms underlying human metabolism and brain function [14]. This has been the case despite the existence of literature from the field of "nutrigenomics", which has specifically studied the effects of food and food ingredients on gene expression. In identifying the public health and the social and/or environmental determinants of disease, it seems invalid to study epidemiology without nutrigenomics, or vice versa. In other words, a more macro-level approach to unraveling the full range of environmental and genetic factors contributing to these kinds of neurological disorders ought to include nutrition factors as a component of the environment. By combining information derived from both nutrigenomic and epidemiology studies, a macroepigenetic model has already been developed to explain some of the gene-environment interactions with dietary factors that lead to the development of autism and ADHD [4].

Figure 1 shows the Mercury Toxicity model that provides a macroepigenetic explanation of how human neurodevelopment can be adversely impacted when gene expression is altered by dietary transcription factors such as zinc insufficiency or deficiency, or by exposure to toxic substances found in our environment, such as the heavy metals mercury and copper [4]. Elimination of heavy metals requires the expression of the metallothionein (MT) gene, which synthesizes the Zn-dependent metal binding protein metallothionein [15]. With dietary zinc (Zn) loss and copper (Cu) gain from the consumption of high fructose corn syrup (HFCS) [16], metabolic processes required to eliminate heavy metals are impaired in children with autism [4]. Mercury has been found in samples of high fructose corn syrup and is allowable in trace amounts in certain food colors so long as the concentration does not exceed one part per million [17,18]. Mercury (Hg) and specific other heavy metals, including lead (Pb), copper (Cu), cadmium (Cd), silver (Ag) and bismuth (Bi), are capable of displacing the Zn atom in the MT protein molecule [15]. This 'pathogenic' displacement of Zn impairs the MT molecule and its ability to pick up the heavy metal and carry it out of the body. If the diet is deficient in Zn or the absorption of Zn is impaired, then the body may not produce enough MT protein to carry and excrete the heavy metal load [19,20]. Children with autism may be Zn deficient and often have MT dysfunction [21-23]. Because of their diminished capacity to excrete toxic heavy metals, the severity of their condition is associated with their toxic metal burden [24]. This macroepigenetic model proposes that autism prevalence is related to the consumption of HFCS and the overall exposure to Hg in the U.S. [4]. However, other dietary factors associated with the consumption of HFCS may further contribute to the development of autism in the U.S.

thumbnailFigure 1. The original Mercury Toxicity Model. The original Mercury Toxicity Model was published in 2009 by Dufault et al. in the Behavioral and Brain Functions journal. The model is a flow chart of what can happen in the body when there is exposure to mercury (Hg) from ingestion of foods (via HFCS, food colors and fish) or inhalation of air. Human neurodevelopment can be adversely impacted when MT gene expression is altered or suppressed by dietary transcription factors such as zinc (Zn) insufficiency or deficiency. Without proper MT expression and function, mercury excretion may not be possible and oxidative stress in the brain from mercury insult leads to reduced neuronal plasticity and impaired learning. Hg in fish is a problem when there is not enough selenium (Se) in the fish to counteract the Hg and the glutathione (GSH) system is disrupted leading to further oxidative stress.

Additional dietary factors associated with consumption of HFCS

U.S. per capita consumption of HFCS in 2009 was 35.7 pounds per year [25]. The peak years for annual consumption of HFCS coincided with the peak growth rates of ASD in California, the only state that reports number of cases of ASD dating back to the mid-1980s [4]. The Mercury Toxicity Model shows the HFCS characteristics most likely contributing to autism include the zinc-depleting effect that comes from consuming HFCS and certain food colors found in processed foods, and the additional Hg exposure that may occur from the low Hg concentrations sometimes found in HFCS as a result of the manufacturing process [4,17]. This model can be expanded to include additional adverse effects associated with the consumption of HFCS that likely contribute to the development of autism through PON1 gene modulation and lead intoxication.

U.S. Department of Agriculture (USDA) scientists warn that when dietary intake of magnesium (Mg) is low, consumption of HFCS leads to lower calcium (Ca) and phosphorus (P) balances adversely affecting macromineral homeostasis in humans [26]. This is an unfortunate finding because there is evidence to suggest that dietary intake of Mg is low among Americans, most of whom consume a high fructose diet. In 2003, CDC scientists reported that substantial numbers of U.S. adults fail to consume adequate Mg in their diets [27]. Children with autism were found to have significantly lower plasma Mg concentrations than normal subjects [28]. Adams et al. found significant reductions in red blood cell (RBC) Ca, serum and white blood cell (WBC) Mg and an increase in RBC copper in autistic children as compared to controls [29]. Recently, USDA scientists reported that the National Health and Nutrition Examination Survey (NHANES) data for 2005 to 2006 indicate that overall, nearly one half of all individuals one year and over had inadequate intakes of dietary Mg [30]. With a substantial number of Americans consuming inadequate amounts of dietary Mg along with HFCS diets, one may predict that substantial numbers of Americans are likely experiencing a calcium (Ca) deficit as well.

Insufficient intake of dietary Ca, Mg and Zn, or losses or displacement of any of these minerals from the consumption of HFCS, may further enhance the toxic effects of lead (Pb) on cognitive and behavioral development in children [31]. A significant and independent inverse relationship between dietary Ca intake and blood Pb concentrations was found in 3,000 American children examined as part of NHANES II [32]. Elevated blood Pb levels are indicative of Pb intoxication, which is found in some children diagnosed with autism and associated with the development of ADHD [33,34]. It may be that inadequate intake of Ca or Mg combined with a HFCS zinc-depleting diet increases the risk of developing autism and ADHD from Pb intoxication.

Inadequate intake of Ca or Mg may further contribute to these developmental disorders by impacting human serum paraoxonase-1 (PON1) gene expression. PON1 is a calcium dependent enzyme responsible for OP pesticide detoxification as well as hydrolysis of the thiolactone form of homocysteine [35,36]. PON1 is synthesized in the liver and secreted in blood where it is incorporated into high density lipoproteins (HDL). The availability and catalytic activity of PON1 are impaired in many children with ASD making them more susceptible to the toxic effects of OP pesticide residues which are most frequently found in grain [37,38]. Figure 2 shows the expanded Mercury Toxicity Model that includes changes both in Pb toxicity and PON1 activity when dietary intake of Mg is low and consumption of HFCS leads to greater loss of calcium (Ca) and phosphorus (P), thereby adversely affecting macromineral homeostasis.

thumbnailFigure 2. The expanded Mercury Toxicity Model. Figure 2 shows the expanding Mercury Toxicity Model that includes changes both in lead (Pb) toxicity and human serum paraoxonase (PON1) activity when dietary intake of Mg is low and consumption of high fructose corn syrup (HFCS) leads to lower calcium (Ca) and phosphorus (P) balances, adversely affecting macromineral homeostasis. With insufficient dietary intake of Ca and/or Mg, children become more susceptible to Pb intoxication and OP exposures with decreasing PON1 activity. Pb intoxication and OP exposures can both lead to oxidative stress in the brain reducing neuronal plasticity.

PON1 activity and organophosphate exposure in U.S

One can assert that with the consumption of a HFCS intensive diet and inadequate Mg intakes, PON1 activity may decrease, along with resulting Ca losses in genetically predisposed individuals. Although there are no human data yet to support this assertion, PON1 activity in rats decreased when fed a HFCS diet to mimic the human metabolic syndrome [39]. PON1 activity has been extensively studied in humans and there are a number of factors known to modulate or alter PON1 expression including, but not limited to, Hg exposure, sex and age [40,41]. Age plays the most relevant role, as PON1 activity is very low before birth and gradually increases during the first few years of life in humans [41]. In one study, scientists at UC Berkeley found the PON1 levels in many children may remain lower than those of their mothers for several years, especially those with genotypes associated with decreased PON1 activities [42]. The scientists concluded that these children may be more susceptible to OP pesticides throughout their childhood and more vulnerable to conditions associated with oxidative stress such as autism [42]. In a different study, scientists at UC Berkeley found that two-year-old children were less likely to display symptoms of PDD when their mothers had higher paraoxonase levels during their pregnancy [43]. Proper function and adequate expression of the PON1 gene is essential both for prenatal development and child health because exposure to OP pesticides is a common occurrence in the U.S.

The CDC tracks exposure to OP pesticides or their metabolites through the National Biomonitoring Program (NBP). Exposure data are reported for the population as a whole and for subgroups. While most American groups are exposed to OP pesticides, children ages 6 to 11 have significantly higher exposures than adults and are at greatest risk from OP neurotoxicity [44]. Harvard University researchers recently reported finding OP pesticide residues in a number of foods frequently consumed by children [45]. The researchers expressed concern that the children were at times being exposed to multiple pesticide residues in single food commodities. OP pesticide exposures occur primarily from the consumption of foods containing pesticide residues.

It is well known that pesticide exposure can impair neurodevelopment in children, but recent studies have found that pesticide exposure during pregnancy can also cause delayed mental development in children [46]. A review of epidemiological studies in 2008 found that prenatal and childhood exposure to OPs impairs neurobehavioral development [47]. Higher concentrations of urinary dialkyl phosphate (DAP) measured during pregnancy was significantly associated with lower cognitive scores in children at seven years of age. Those children in the highest quintile of maternal DAP concentrations had an IQ score seven points lower than those children in the lowest quintile [48]. In a group of newborns with the highest levels of the organophosphate chlorpyrifos measurable in their umbilical cord blood, birth weight averaged 150 grams less than the group with the lowest exposure [49]. Prenatal pesticide exposure showed deficits consistent with developmental delays of 1.5 to 2 years [49].

Diet is the main source of OP exposure in children. Under the 1996 Food Quality Protection Act, the U.S. Secretary of Agriculture is directed to collect pesticide residue data on commodities frequently consumed by infants and children. USDA Pesticide Data Program (PDP) provides the residue data to comply with this law [50]. We reviewed the PDP data from 2004 to 2008 and identified the foods most frequently found to contain organophosphate insecticide residues. In addition, we obtained the per capita availability data from the USDA to determine the amount of each food commodity the average American consumes [25]. The results of our review indicate that wheat and corn are the commodities most likely contributing to OP exposure in U. S. children. Estimated per capita wheat consumption was approximately 95 pounds per year while estimated per capita corn consumption was approximately 23 pounds per year. The primary use of corn is for the production of corn sweeteners, such as HFCS; however, pesticide residue data were not gathered for this commodity by the PDP. Table 2 provides a complete breakdown of the results of this data review.

Table 2. PDP residue detections by year sampled wi th U.S. per capita consumption data

From Table 2 it is clear consumers are at risk of exposure to multiple OP pesticide residues from consuming the very same commodity. Cumulative exposures will continue to occur in the U.S. where OP pesticide use is widespread by the agricultural industry. Although OP pesticide use is equally widespread in other countries, there is genetic variation across populations that determine degree of susceptibility to OP exposure. The PON1 gene variants associated with autism in subgroups of the U.S. population but not in Italy could be attributed to the fact that HFCS consumption rarely occurs in Italy, thereby lessening the conditions for PON1 modulation.

HFCS consumption and PON1 modulation in autism in the U.S

In the 27-member European Union (EU), of which Italy is an original participant, HFCS is known as "isoglucose" and currently it is rarely consumed by Italians. Americans on the other hand consume on average 35.7 pounds per year, which may increase their overall Hg exposure [17,25]. Figure 3 shows U.S. per capita food consumption in pounds per year for HFCS beginning in the early 1970s and increasing throughout the 1980s to reach a peak between 1999 and 2002. In our previous publication, we reported the peak years for annual consumption of HFCS in the U.S. occurred within the same period as when the annual growth rates of autism peaked in California [4].

thumbnailFigure 3. U.S. per capita consumption of high fructose corn syrup 1966-2004. Figure 3 shows the United States (US) per capita consumption of high fructose corn syrup (HFCS) in pounds per year as calculated by the United States Department of Agriculture (USDA)/Economic Research Service.

American per capita consumption of HFCS has exceeded 20 pounds per year since 1980 while Italians consume negligible amounts of the same ingredient. As was previously mentioned, mercury (Hg) and fructose may both modulate PON1 activity [39-41]. While excessive fructose exposure in the U.S. may primarily occur through the consumption of foods containing HFCS, mercury exposure may occur in a number of ways. A comparison of common sources of mercury exposure in the U.S. and Italy may offer a further explanation of the PON1 gene variation associated with autism in the U.S. but not in Italy.

In addition to HFCS, primary sources of inorganic and elemental Hg exposure may occur from consumption of food colors and preservatives made with mercury-cell chlorine or chlor-alkali products, seafood consumption, Hg in dental amalgam, thimerosal in vaccines, and depending on geographic location, inhalation of Hg contaminated air [4,51-54]. Children living near coal-fired power plants are often exposed to higher levels of Hg in their breathing air and have a higher prevalence of autism [55]. Because Hg emissions from coal-fired power plants are not yet regulated in either the U.S. or Italy, this particular source of Hg exposure is unlikely to explain the overall difference in autism prevalence between these two countries. With respect to the consumption of seafood, use of Hg dental amalgam, thimerosal in vaccines or Hg-containing food colors and preservatives, there is also no appreciable difference between Italy and the U.S. [56-58]. The only remaining variable in our model is the excessive consumption of HFCS by Americans, which results in greater chronic exposures to both inorganic Hg and, by definition, fructose [4].

Inorganic Hg may interact with cysteine residues on PON1 preventing its activation in the liver and impairing the body's ability to protect itself against OP pesticides and oxidative stressors involved in autism [41]. As noted above, PON1 is responsible for hydrolysis of homocysteine thiolactone, and plasma PON1 activity is negatively correlated with homocysteine levels [36,59]. Homocysteine is a metabolic biomarker for oxidative stress and impaired methylation capacity. A recent study of the Inuit population found a significant inverse correlation between PON1 activity and Hg levels, as well as a direct correlation with selenium levels [60]. With increasing Hg and fructose exposure and reductions in dietary Ca, one can expect to see reduced PON1 activity and increasing homocysteine levels in children with ASD.

Indeed, Pasca et al. recently reported finding that both PON1 arylesterase and PON1 paraoxonase activities were decreased in children with autism [61,62]. James et al. found that children with autism had higher plasma homocysteine levels than controls but demonstrated significant improvements in transmethylation metabolites and glutathione (GSH) after receiving folate and vitamin B12 [63]. Patel and Curtis found that in addition to glutathione and B12 injections one to three times per week, children with autism and ADHD showed significant improvement in many areas of social interaction, concentration, writing, language and behavior when fed an organic diet low in fructose and free of food additives and food colors [64].

Mothers of autistic children in the U.S. were also found to have significant increases in mean plasma homocysteine levels compared to controls [65]. Schmidt et al. found that women who took vitamin supplements during the periconceptional period reduced the risk of autism in their children [66]. Those women who did not take vitamins during this period were more likely to have a child with autism and were at even greater risk when they had specific genetic variants within one-carbon metabolism pathways. This suggests that folate and other dietary methyl donors may alter epigenetic regulation of gene expression in their children, thereby reducing the risk of autism [66].

Methionine synthase links oxidation to epigenetics

Epigenetic regulation of gene expression is highly dependent upon methylation of both DNA and histones, and methylation capacity is in turn dependent upon activity of the folate and vitamin B12-dependent enzyme methionine synthase, which converts homocysteine to methionine. Lower methionine synthase activity decreases the level of the methyl donor S-adenosylmethionine (SAM) while simultaneously increasing the level of the methylation inhibitor S-adenosylhomocysteine (SAH) [67]. The combined effect of changes in the SAM to SAH ratio, therefore, exerts a powerful influence over more than 200 methylation reactions, including DNA and histone methylation [68].

Methionine synthase activity is inhibited by oxidative stress, and its inhibition results in the diversion of homocysteine to produce the antioxidant glutathione (GSH), providing an important adaptive response [69]. However, oxidative inhibition of methionine synthase leads to epigenetic effects via the resultant decrease in the SAM to SAH ratio and decreased DNA and histone methylation. Epigenetic changes in gene expression can recruit further adaptive responses to oxidative stress. Figure 4 illustrates how these changes may occur when the body is under oxidative stress from exposure to OP pesticides, heavy metals, and calcium depleting substances, such as HFCS. Decreased methionine synthase activity during oxidative stress also increases homocysteine thiolactone formation [70], raising the importance of PON1. As was previously mentioned, PON1 is essential for reducing homocysteine levels, which are thought to be harmful. Elevated plasma homocysteine (tHcy) levels are associated with genome-wide DNA hypomethylation that may carry over from one generation to the next, increasing the risk of autism [71]. Epigenetic changes affecting germline cells can give rise to these transgenerational effects [72]. James et al. found that parents share similar metabolic deficits in methylation capacity and glutathione-dependent antioxidant/detoxification capacity with their children with autism [71].

thumbnailFigure 4. Methionine synthase links oxidative stress to epigenetic regulation. Figure 4 shows how exposure to toxic substances, such as OP pesticides, HFCS, or heavy metals, inhibits methionine synthase through effects of oxidative stress. As a result, decrease of SAM to SAH ratio will lead to a decrease in DNA methylation and consequently to altered PON1 gene expression.

Synergistic effect of multiple neurotoxins

Based upon the discussion above, it is clear that methionine synthase activity is crucial for translating changes in oxidative status into epigenetic effects, and this role is confirmed by the improved metabolic profile in autistic subjects given folate and vitamin B12 [63]. This relationship has given rise to the "Redox/Methylation Hypothesis of Autism", which proposed that oxidative insults arising from environmental exposures, such as Hg and pesticides, can cause neurodevelopmental disorders by disrupting epigenetic regulation [73]. The macroepigenetic Mercury Toxicity Model expanded in this paper provides additional support for the "Redox/Methylation Hypothesis of Autism" while contributing important insight into the oxidative stress feedback mechanisms that may occur as a result of malnutrition resulting from dietary exposures to toxins. The delivery of children exhibiting autistic behaviors might be associated with the prenatal diet of their mothers. The severity of these behaviors can be further exacerbated by toxic dietary exposures of the children, which can improve with dietary changes aimed at eliminating these exposures. Children with autism could well be exhibiting an epigenetic response to several neurotoxic substances at once, including, but not limited to, inorganic Hg, Pb, OP pesticides and/or HFCS. The combined effect of these substances acting together is likely greater than the sum of the effects of the substances acting by themselves. This effect likely reduces neuronal plasticity and impairs learning capacity in autistic children.

Conclusion

The number of children ages 6 to 21 in the U.S. receiving special education services under the autism disability category increased 91% between 2005 to 2010 despite fewer children receiving special education services overall during the same time period. A comparison of autism prevalence between the U.S. and Italy using the Mercury Toxicity Model suggests the increase in autism in the U.S. is not related to mercury exposure from fish, coal-fired power plants, thimerosal, or dental amalgam but instead to the consumption of HFCS. Consumption of HFCS may lead to mineral imbalances, including Zn, Ca and P loss and Cu gain and is a potential source of inorganic mercury exposure. These mineral imbalances create multiple pathways for oxidative stress in the brain from exposure to OP pesticides and heavy metals, such as Pb or Hg. Inorganic mercury and fructose exposure from HFCS consumption may both modulate PON1 gene expression. With a reduction in PON1 activity, there is a potential for increasing homocysteine levels which are associated with genome-wide DNA hypomethylation that may carry over from one generation to the next, affecting both neurodevelopment and autism prevalence.

Abbreviations

ADHD: Attention-Deficit-Hyperactivity-Disorder; Ag: Silver; APA: American Psychiatric Association; ASD: Autism Spectrum Disorder; Bi: Bismuth; Ca: Calcium; Cd: Cadmium; CDC: Center for Disease Control and Prevention; Cu: Copper; DAP: Dialkyl phosphate; DSM: Diagnostic and Statistical Manual of Mental Disorders; EU: European Union; GSH: Glutathione; HDL: High density lipoprotein; HFCS: High fructose corn syrup; Hg: Mercury; Mg: Magnesium; MT: Metallothionein; NBP: National Biomonitoring Program; NHANES: National Health and Nutrition Examination Survey; OHI: Other Health Impaired; OP: organophosphate pesticide; P: phosphorus; Pb: lead; PDD: Pervasive Developmental Delay; PDP: Pesticide Data Program; PON1: paraoxonase-1; RBC: red blood cell; SAH: S-adenosylhomocysteine; SAM: S-adenosylmethionine; tHcy: total plasma homocysteine; USDA: United States Department of Agriculture; WBC: White blood cell; Zn: Zinc.

Competing interests

RDeth has in the past received compensation as an expert witness on the topic of autism. All of the other authors declare that they have no competing interests.

Authors' contributions

RDufault spearheaded the review and recruited interdisciplinary collaborators to contribute to the development of the manuscript. RDufault was the lead investigator and literature reviewer for the expansion of the mercury toxicity model. RDufault acquired, analyzed and interpreted the new data sets. WJL, RS and RDeth helped revise the manuscript critically for important intellectual content. RDeth provided Figure 4 and was the primary author of the methionine synthase section. All authors read and approved the final manuscript. RS validated all of the references. RC validated the data in Table 1 to ensure it was correctly gathered from existing data bases. RC also double checked the calculations in Table 1 to ensure they were error free. DW helped draft and edit the manuscript.

Lead author's information

After retiring with honors from her position as an environmental health officer with the U.S. Public Health Service, R. Dufault obtained her teaching license and taught elementary special education for 3.5 years at which time she gained an understanding of how children with autism and ADHD in the U.S. receive special education services. As a volunteer, she currently teaches an epigenetics course on-line through the Food Ingredient and Health Research Institute.

Acknowledgements

The authors would like to thank Drs. Robert Lustig, Blaise LeBlanc and Steven Gilbert for the feedback each provided on this manuscript and/or the concepts therein. Funding for this research project was provided primarily by donations to the Food Ingredient and Health Research Institute. Research in the Lukiw laboratory is supported through Grant Number P20RR016456 from the National Center for Research Resources, a Translational Research Initiative Grant from LSU Health Sciences Center New Orleans, an Alzheimer Association Investigator-Initiated Research Grant IIRG-09-131729, and NIH NIA Grants AG18031 and AG038834.

References

  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: Text Revision (DSM-IV-TR); 2000. OpenURL

  2. Yerys BE, Wallace GL, Sokoloff JL, Shook DA, James JD, Kenworthy L: Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders.

    Autism Res 2009, 2:322-333. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  3. D'Amelio M, Ricci I, Sacco R, Liu X, D'Agruma L, Muscarella LA, Guarnieri V, Militerni R, Bravaccio C, Elia M, Schneider C, Melmed R, Trillo S, Pascucci T, Puglisi-Allegra S, Reichelt KL, Macciardi F, Holden JJA, Persico AM: Paraoxonase gene variants are associated with autism in north America, but not in italy: possible regional specificity in gene-environment interactions.

    Mol Psychiatry 2005, 10:1006-1016. PubMed Abstract | Publisher Full Text OpenURL

  4. Dufault R, Schnoll R, Lukiw WJ, LeBlanc B, Cornett C, Patrick L, Wallinga D, Gilbert SG, Crider R: Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children.

    Behav Brain Funct 2009, 5:44. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  5. Caspi A, Moffitt TE: Gene-environment interactions in psychiatry: joining forces with neuroscience.

    Nat Rev Neurosci 2006, 7:583-590. PubMed Abstract | Publisher Full Text OpenURL

  6. United States Centers for Disease Control and Prevention: Errata: vol. 58, no. SS-10. [http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5930a5.htm] webcite

    MMWR 2010, 59:956. OpenURL

  7. United States Centers for Disease Control and Prevention: Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, United States, 2006.

    MMWR 2009, 58:1-20. PubMed Abstract | Publisher Full Text OpenURL

  8. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Chandour RM, Singh GK, Strickland BB, Trevathan E, van Dyck PC: Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007.

    Pediatrics 2009, 124(5):1395-1403. PubMed Abstract | Publisher Full Text OpenURL

  9. Newschaffer CJ, Falb MD, Gurney JG: National autism prevalence trends from united states special education data.

    Pediatrics 2005, 115:e277-282. PubMed Abstract | Publisher Full Text OpenURL

  10. Data Accountability Center: Individuals with Disabilities Education Act (IDEA) Data. [http://www.ideadata.org/PartBData.asp] webcite

  11. Boyle CA, Boulet S, Schieve LA, Blumberg SJ, Yeargin-Allsopp M, Visser S, Kogan MD: Trends in the prevalence of developmental disabilities in US children, 1997-2008.

    Pediatrics 2011, 127:1034-1042. PubMed Abstract | Publisher Full Text OpenURL

  12. Iafusco D, Vanelli M, Songini M, Chiari G, Cardella F, Fifi A, Lombardo F, Marinaro A, Melia A, Marsciani A, Vacca A, Prisco F: Type 1 diabetes and autism association seems to be linked to the incidence of diabetes.

    Diabetes Care 2006, 29(8):1985-1986. PubMed Abstract | Publisher Full Text OpenURL

  13. Zahir FR, Brown CJ: Epigenetic impacts on neurodevelopment: patholphysiological mechanisms and genetic modes of action.

    Pediatr Res 2011, 69:92R-100R. PubMed Abstract | Publisher Full Text OpenURL

  14. Mutch DM, Wahli W, Williamson G: Nutrigenomics and nutrigenetics: the emerging faces of nutrition.

    FASEB J 2005, 19:1602-1616. PubMed Abstract | Publisher Full Text OpenURL

  15. Coyle P, Philcox JC, Carey LC, Rofe AM: Metallothionein: the multipurpose protein.

    Cell Mol Life Sci 2002, 59:627-647. PubMed Abstract | Publisher Full Text OpenURL

  16. Ivaturi R, Kies C: Mineral balances in humans as affected by fructose, high-fructose corn syrup, and sucrose.

    Plant Foods Hum Nutr 1992, 42:143-151. PubMed Abstract | Publisher Full Text OpenURL

  17. Dufault R, LeBlanc B, Schnoll R, Cornett C, Schweitzer L, Wallinga D, Hightower J, Patrick L, Lukiw WJ: Mercury from chlor-alkali plants: measured concentrations in food product sugar.

    Environ Health 2009, 8:2. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text OpenURL

  18. United States Code of Federal Regulations. Part 74 - Listing of Food Color Additives Subject to Certification [http:/ / ecfr.gpoaccess.gov/ cgi/ t/ text/ text-idx?c=ecfr&sid=1070b19eb50e562 daa872cfa1755aa09&rgn=div5&view=tex t&node=21:1.0.1.1.27&idno=21#21:1.0 .1.1.27.1.31.9] webcite

  19. Shankar AH, Prasad AS: Zinc and immune function: the biological basis of altered resistance to infection.

    Am J Clin Nutr 1998, 68:447S-463S. PubMed Abstract | Publisher Full Text OpenURL

  20. Szczurek EI, Bjornsson CS, Taylor CG: Dietary zinc deficiency and repletion modulate metallothionein immunolocalization and concentration in small intestine and liver of rats.

    J Nutr 2001, 131:2132-2138. PubMed Abstract | Publisher Full Text OpenURL

  21. Yorbik O, Akay C, Sayal A, Cansever A, Sohmen T, Cavdar AO: Zinc status in autistic children.

    J Trace Elem Exp Med 2004, 17:101-107. Publisher Full Text OpenURL

  22. Faber S, Zinn GM, Kern JC, Kingston HM: The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders.

    Biomarkers 2009, 14:171-180. PubMed Abstract | Publisher Full Text OpenURL

  23. Yasuda H, Yoshida K, Yasuda Y, Tsutsui T: Infantile zinc deficiency: association with autism spectrum disorders.

    Sci Rep 2011, 1:129. PubMed Abstract | PubMed Central Full Text OpenURL

  24. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newsmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr JM: The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels.

    J Toxicol 2009:532640. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  25. United States Department of Agriculture: Economic Research Service - Data Sets. Loss-Adjusted Food Availability: Spreadsheets. [http://www.ers.usda.gov/Data/FoodConsumption/FoodGuideSpreadsheets.htm#sugar] webcite

  26. Milne DB, Nielsen FH: The interaction between dietary fructose and magnesium adversely affects macromineral homeostasis in men.

    J Am Coll Nutr 2000, 19:31-37. PubMed Abstract OpenURL

  27. Ford ES, Mokdad AH: Dietary magnesium intake in a national sample of US adults.

    J Nutr 2003, 133:2879-2882. PubMed Abstract | Publisher Full Text OpenURL

  28. Strambi M, Longini M, Hayek J, Berni S, Macucci F, Scalacci E, Vezzosi P: Magnesium profile in autism.

    Biol Trace Elem Res 2006, 109:97-104. PubMed Abstract | Publisher Full Text OpenURL

  29. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W: Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity.

    Nutr Metab (London) 2011, 8:34. BioMed Central Full Text OpenURL

  30. United States Department of Agriculture: What We Eat in America, NHANES 2005-2006. [http:/ / www.ars.usda.gov/ SP2UserFiles/ Place/ 12355000/ pdf/ 0506/ usual_nutrient_intake_vitD_ca_phos_ mg_2005-06.pdf] webcite

  31. Goyer RA: Nutrition and metal toxicity.

    Am J Clin Nutr 1995, 61:646S-650S. PubMed Abstract | Publisher Full Text OpenURL

  32. Mahaffey KR, Gartside PS, Glueck CJ: Blood lead levels and dietary calcium intake in 1 to 11 year-old children: the second national health and nutrition examination survey, 1976 to 1980.

    Pediatrics 1986, 78:257-262. PubMed Abstract OpenURL

  33. Shannon M, Graef JW: Lead intoxication in children with pervasive developmental disorders.

    J Toxicol Clin Toxicol 1996, 34:177-181. PubMed Abstract | Publisher Full Text OpenURL

  34. Eubig PA, Aguiar A, Schantz SL: Lead and PCBs as risk factors for attention deficit/hyperactivity disorder.

    Environ Health Perspect 2010, 118:1654-1667. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  35. Josse D, Xie W, Renault F, Rochu D, Schopfer LM, Masson P, Lockridge O: Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities.

    Biochemistry 1999, 38:2816-2825. PubMed Abstract | Publisher Full Text OpenURL

  36. Jakubowski H: The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.

    Adv Exp Med Biol 2010, 660:113-127. PubMed Abstract | Publisher Full Text OpenURL

  37. Pasca SP, Dronca E, Nemes B, Kaucsar T, Endreffy E, Iftene F, Benga I, Cornean R, Dronca M: Paraoxonase 1 activities and polymorphisms in autism spectrum disorders.

    J Cell Mol Med 2010, 14:600-607. PubMed Abstract | Publisher Full Text OpenURL

  38. Dufault R, Gilbert SG: Implications of Organophosphate (OP) Pesticides in Food Grain. In Poster Presented at the Society of Toxicology Conference. Washington, DC; 2011. OpenURL

  39. Ackerman Z, Oron-Herman M, Pappo O, Peleg E, Safadi R, Schmilovitz-Weiss H, Grozovski M: Hepatic effects of rosiglitazone in rats with the metabolic syndrome.

    Basic Clin Pharmacol Toxicol 2010, 107:663-668. PubMed Abstract | Publisher Full Text OpenURL

  40. Costa LG, Giordano G, Furlong CE: Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

    Biochem Pharmacol 2011, 81:337-344. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  41. Costa LG, Vitalone A, Cole TB, Furlong CE: Modulation of paraoxonase (PON1) activity.

    Biochem Pharmacol 2005, 69:541-550. PubMed Abstract | Publisher Full Text OpenURL

  42. Huen K, Harley K, Bradman A, Eskenazi B, Holland N: Longitudinal changes in PON1 enzymatic activities in mexican-american mothers and children with different genotypes and haplotypes.

    Toxicol Appl Pharmacol 2010, 244:181-189. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  43. Eskenazi B, Huen K, Marks A, Harley KG, Bradman A, Barr DB, Holland N: PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero.

    Environ Health Perspect 2010, 118:1775-1781. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  44. Barr DB, Bravo R, Weerasekera G, Caltabiano LM, Whitehead RD Jr, Olsson AO, Caudill SP, Schober SE, Pirkle JL, Sampson EJ, Jackson RJ, Needham LL: Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the US population.

    Environ Health Perspect 2004, 112:186-200. PubMed Abstract | PubMed Central Full Text OpenURL

  45. Lu C, Schenck FJ, Pearson MA, Wong JW: Assessing children's dietary pesticide exposure: direct measurement of pesticide residues in 24-hr duplicate samples.

    Environ Health Perspect 2010, 118:1625-1630. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  46. Harari R, Julvez J, Murata K, Barr D, Bellinger DC, Debes F, Grandjean P: Neurobehavioral deficits and increased blood pressure in school-age children prenatally exposed to pesticides.

    Environ Health Perspect 2010, 118:890-896. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  47. Jurewicz J, Hanke W: Prenatal and childhood exposure to pesticides and neurobehavioral development: review of epidemiological studies.

    Int J Occup Med Environ Health 2008, 21:121-132. PubMed Abstract | Publisher Full Text OpenURL

  48. Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, Calderon N, Trujillo C, Johnson C, Bradman A, Barr DB, Eskenazi B: Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children.

    Environ Health Perspect 2011, 119:1189-1195. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  49. Perera FP, Rauh V, Whyatt RM, Tang D, Tsai WY, Bernert JT, Tu YH, Andrews H, Barr DB, Camann DE, Diaz D, Dietrich J, Reyes A, Kinney PL: A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures.

    Neurotoxicology 2005, 26:573-587. PubMed Abstract | Publisher Full Text OpenURL

  50. United States Department of Agriculture: Agricultural Marketing Service. Science and Laboratories. PDP - Databases and Annual Summaries. [http:/ / www.ams.usda.gov/ AMSv1.0/ ams.fetchTemplateData.do?template=T emplateG&topNav=&leftNav=Scienceand Laboratories&page=PDPDownloadData/ Reports&description=Download+PDP+Da ta/ Reports&acct=pestcddataprg] webcite

  51. Mahaffey KR, Clickner RP, Jeffries RA: Adult women's blood mercury concentration vary regionally in the United States: association with patterns of fish consumption (NHANES 1999-2004).

    Environ Health Perspect 2009, 117:47-53. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  52. Oskarsson A, Schultz A, Skerfving S, Hallen IP, Ohlin B, Lagerkvist BJ: Total and inorganic mercury in breast milk and blood in relation to fish consumption and amalgam fillings in lactating women.

    Arch Environ Health 1996, 51:234-241. PubMed Abstract | Publisher Full Text OpenURL

  53. United States Food and Drug Administration: Ongoing Response to Vaccine and Autism Issues. [http://www.fda.gov/NewsEvents/Testimony/ucm115158.htm] webcite

  54. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK: Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area.

    Environ Health Perspect 2006, 114:1438-1444. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  55. Palmer RF, Blanchard S, Wood R: Proximity to point sources of environmental mercury release as a predictor of autism prevalence.

    Health Place 2008, 15:18-24. PubMed Abstract | Publisher Full Text OpenURL

  56. Barbone F, Valent F, Mazej D, Tratnik J, Spiric Z, Prpic I, Sofianou-Katsoulis A, Nakou S, Little D, Mariuz M, Miklavcic A, Neubauer D, Rosolen V, Petrovic O, Parpinel M, Bin M, Tognin V, Carrozzi M, Osredkar J, Horvat M: The Association of Mercury, Fish Consumption and Child Development in a Mediterranean Cohort. In The 10th International Conference on Mercury as a Global Pollutant. Halifax, NS, Canada: FS19-01; 2011. OpenURL

  57. European Commission: Review of the Community Strategy Concerning Mercury. Final Report, 2010. [http:/ / ec.europa.eu/ environment/ chemicals/ mercury/ pdf/ review_mercury_strategy2010.pdf] webcite

  58. Valent F, Pisa F, Mariuz M, Horvat M, Gibicar D, Fajon V, Mazej D, Daris F, Barbone F: Fetal and perinatal exposure to mercury and selenium: baseline evaluation of a cohort of children in Friuli Venezia Giulkia, Italy.

    Epidemiol Prev 2011, 35(1):33-42. PubMed Abstract OpenURL

  59. Lacinski M, Skorupski W, Cieslinski A, Sokolowska J, Trzeciak WH, Jakubowski H: Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.

    Cell Mol Biol 2004, 50:885-893. PubMed Abstract OpenURL

  60. Ayotte P, Carrier A, Ouellet N, Boiteau V, Abdous B, Sidi EAL, Degat MLC, Dewailly E: Relation between methylmercury exposure and plasma paraoxonase activity in Inuit adults from Nunavik.

    Environ Health Perspect 2011, 119:1077-1083. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  61. Pasca SP, Dronca E, Nemes B, Kaucsar T, Endreffy E, Iftene F, Benga I, Cornean R, Dronca M: Paraoxonase 1 activities and polymorphisms in autism spectrum disorders.

    J Cell Mol Med 2010, 14:600-607. PubMed Abstract | Publisher Full Text OpenURL

  62. Pasca SP, Nemes B, Vlase L, Gagyi CE, Dronca E, Miu AC, Dronca M: High levels of homocysteine and low serum paraoxanase 1 arlesterase activity in children with autism.

    Life Sci 2006, 78:2244-2248. PubMed Abstract | Publisher Full Text OpenURL

  63. James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW: Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism.

    Am J Clin Nutr 2009, 89:425-430. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  64. Patel K, Curtis LT: A comprehensive approach to treating autism and attention-deficit hyperactivity disorder: a prepilot study.

    J Altern Complement Med 2007, 13:1091-1097. PubMed Abstract | Publisher Full Text OpenURL

  65. James SJ, Melnyk S, Jernigan S, Lehman S, Seidel L, Gaylor DW, Cleves MA: A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism.

    Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1209-1220. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  66. Schmidt RJ, Hansen Rl, Hartiala J, Allayee H, Schmidt LC, Tancredi DJ, Tassone F, Hertz-Picciotto I: Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism.

    Epidemiology 2011, 22:476-485. PubMed Abstract | Publisher Full Text OpenURL

  67. Matthews RB, Sheppard C, Goulding C: Methylenetetrahydrofoloate reductase and methionine synthase: biochemistry and molecular biology.

    Eur J Pediatr 1998, 157:s54-59. PubMed Abstract | Publisher Full Text OpenURL

  68. Petrossian TC, Clarke SG: Uncovering the human methyltransferasome.

    Mol Cell Proteomics 201, 10:M110.00097. OpenURL

  69. Zou CG, Banerjee R: Homocysteine and redox signaling.

    Antioxid Redox Signal 2005, 7:547-559. PubMed Abstract | Publisher Full Text OpenURL

  70. Jakubowski H, Perla-Kajan J, Finnell RH, Cabrera RM, Wand H, Gupta S, Kruger WD, Kraus JP, Shih DM: Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice.

    FASEB J 2009, 23:1721-1727. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  71. James SJ, Melnyk S, Jernigan S, Hubanks A, Rose S, Gaylor DW: Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism.

    J Autism Dev Disord 2008, 38:1966-1975.

    Erratum in J Autism Dev Disord 2008, 38:1976. Jill James, S [corrected to James, S Jill]

    PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  72. Guerrero-Bosagna C, Skinner MK: Environmentally induced epigenetic transgenerational inheritance of phenotype and disease.

    Mol Cell Endocrinol 2012, 354:3-8. PubMed Abstract | Publisher Full Text OpenURL

  73. Deth R, Muratore C, Benzecry J, Power-Charmitsky VA, Waly M: How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis.

    Neurotoxicology 2008, 29:190-201. PubMed Abstract | Publisher Full Text OpenURL